Bulk ex vivo and single-cell in vivo CRISPR knockout screens are used to characterize 680 chromatin factors during mouse hematopoiesis, highlighting lineage-specific and normal and leukemia-specific functions.
- David Lara-Astiaso
- Ainhoa Goñi-Salaverri
- Brian J. P. Huntly